Synthesis and Anticancer Effect of a Vindoline-Based Bis-Alkylated Resorcinol Derivative
Periodica Polytechnica Chemical Engineering · 02.06.2026 · 70 (2) · 208-214
DOI: 10.3311/ppch.43504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Periodica Polytechnica Chemical Engineering, online erschienen am 02.06.2026. Verfasst von Mónika Halmai und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Alkylation of the simple polyphenol model resorcinol with 10-chloroacetamidovindoline resulted in the corresponding O,O-disubstituted derivative containing two elements of the Vinca alkaloid. The in vitro anticancer activity of the hybrid was investigated on the NCI-60 human tumor cell line panel, and the most important value was obtained on UO-31 renal cancer cells (50% growth inhibition GI50 = 0.893 µM).
Zitieren
APA
Halmai, M., Nagy, N., Mayer, S., Keglevich, P., & Hazai, L. (2026). Synthesis and Anticancer Effect of a Vindoline-Based Bis-Alkylated Resorcinol Derivative. Periodica Polytechnica Chemical Engineering, 70(2), 208-214. https://doi.org/10.3311/ppch.43504
Vancouver
Halmai M, Nagy N, Mayer S, Keglevich P, Hazai L. Synthesis and Anticancer Effect of a Vindoline-Based Bis-Alkylated Resorcinol Derivative. Periodica Polytechnica Chemical Engineering. 2026;70(2):208-214. doi:10.3311/ppch.43504
BibTeX
@article{Halmai2026,
author = {Halmai, Mónika and Nagy, Nóra and Mayer, Szabolcs and Keglevich, Péter and Hazai, László},
title = {Synthesis and Anticancer Effect of a Vindoline-Based Bis-Alkylated Resorcinol Derivative},
journal = {Periodica Polytechnica Chemical Engineering},
year = {2026},
volume = {70},
number = {2},
pages = {208--214},
doi = {10.3311/ppch.43504}
}
EUVIMED